Sarepta Therapeutics Inc (SRPT)

74.57 -0.04  -0.05% NASDAQ May 7, 20:00 USD
View Full Chart
Price Chart
View All SRPT News

News

View All Events

Events

Date Type Description
08/05/2021 00:00 Earnings Results Q2 2021 Earnings Results
08/05/2021 16:30 Earnings Calls Q2 2021 Earnings Call
05/05/2021 00:00 Earnings Results Q1 2021 Earnings Results
05/05/2021 16:30 EDT Earnings Calls Q1 2021 Earnings Call
03/01/2021 00:00 Earnings Results Q4 2020 Earnings Results
03/01/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 00:00 Earnings Results Q3 2020 Earnings Results
11/05/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
08/05/2020 16:30 EDT Earnings Calls Q2 2020 Earnings Call
08/05/2020 00:00 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.
  • URL: https://www.sarepta.com
  • Investor Relations URL: http://investorrelations.sarepta.com/phoenix.zhtml?c=64231&p=irol-irhome
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 05, 2021
  • Last Earnings Release: May. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
ETCHX Eventide Healthcare & Life Sciences C 3.87%
FBT First Trust NYSE Arca Biotech ETF 3.51%
INVNX Evolutionary Tree Innovators 2.64%
FONBXX FT Biotechnology 47 RE 2.19%
HQH Tekla Healthcare Investors 2.13%
HQL Tekla Life Sciences Investors 2.12%
FFPPLX FT Biotechnology 48 RE 2.05%
IDNA iShares Genomics Immnlgy & Hlthcr ETF 1.65%
ARKG ARK Genomic Revolution ETF 1.62%
JFNSX Janus Henderson Global Life Sciences S 1.28%
FIJYX Fidelity Advisor® Biotechnology Z 1.01%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.